RESMED INC SEC Filing

Michael Farrell reported a proposed sale of 4,991 shares of Common Stock under Rule 144 on 05/07/2026.

Rhea-AI Filing Summary

Michael Farrell reported a proposed sale of 4,991 shares of Common Stock under Rule 144 on 05/07/2026. The form lists an option granted dated 11/21/2019 and shows three prior sales of 4,991 shares on 02/09/2026, 03/09/2026, and 04/07/2026 with dollar figures provided alongside each sale.

Key Figures

Shares to be sold: 4,991 shares Option grant date: 11/21/2019 Prior sale 1 proceeds: $1,366,436.48 +3 more

6 metrics

Shares to be sold 4,991 shares listed under "Securities To Be Sold" dated 05/07/2026

Option grant date 11/21/2019 appears on the securities-to-be-sold line as "Option Granted - 11/21/2019"

Prior sale 1 proceeds $1,366,436.48 sale on 02/09/2026 for 4,991 shares (figure listed adjacent)

Prior sale 2 proceeds $1,252,901.71 sale on 03/09/2026 for 4,991 shares (figure listed adjacent)

Prior sale 3 proceeds $1,125,486.47 sale on 04/07/2026 for 4,991 shares (figure listed adjacent)

Broker listed Fidelity Brokerage Services LLC broker entry alongside Common stock on form (address shown)

Key Terms

Rule 144, Option Granted, Compensation

3 terms

Rule 144 regulatory

"reported a proposed sale of 4,991 shares under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Option Granted financial

"Option Granted - 11/21/2019 shown on the securities-to-be-sold line"

Compensation financial

"the securities-to-be-sold entry is labeled "Compensation""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 04:28 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001485164
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESMED INC
SEC File Number	001-15317
Address of Issuer	9001 SPECTRUM CENTER BLVD. SAN DIEGO CALIFORNIA 92123
Phone	8587462400
Name of Person for Whose Account the Securities are To Be Sold	Farrell Michael J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4991	1037232.66	145056384	05/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2026	Option Granted - 11/21/2019	Issuer			4991	05/07/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	02/09/2026	4991	1366436.48
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	03/09/2026	4991	1252901.71
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	04/07/2026	4991	1125486.47

144: Remarks and Signature

Remarks
Date of Notice	05/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Louis Kurnick, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)